SOX9 and cancer: Recent studies that have compared the effectiveness and clinical value of liquid biopsy versus tissue biopsy have reported that the former is more clinically valuable based on its ability to accurately detect ARID1A, SOX9, FAM123B, ATM KRAS, PIK3C, and TP53 in patients suffering from a variety of cancers [64–66].